all report title image
  • Published On : Dec 2022
  • Code : CMI5420
  • Industry : Pharmaceutical
  • Pages : 167
  • Formats :

The global veterinary healthcare market was valued at US$ 30,368.5 Mn in 2021 and is forecast to reach the value of US$ 55,657.5 Mn by 2028 at a CAGR of 9.0% between 2022 and 2028. The global veterinary healthcare market is experiencing strong growth due to the increase in incidence or prevalence of zoonosis diseases across the globe and favorable initiatives by governments and animal welfare associations. Moreover, increase in focus on the veterinary healthcare and increase in adoption of pets during the pandemic is expected to boost the growth of the market. However, factors such as high cost of veterinary healthcare services/solutions and availability of counterfeit products or drugs are expected to hamper growth of the market.

Global Veterinary Healthcare Market: Regional Insights

Based on geography, the global veterinary healthcare market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing incidence of zoonotic and chronic diseases and increase in livestock population in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), zoonotic diseases are very common around the world. More than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new and/or emerging infectious diseases in people come from animals. Thus, CDC works 24/7 to protect people from zoonotic diseases in the United States and around the world.

Moreover, Europe and Asia Pacific are expected to witness robust growth in the global veterinary healthcare market due to the increase in focus on veterinary healthcare and favorable government initiatives in these regions. Thus, market players are focusing on developing and launching novel veterinary healthcare products. For instance, in December 2021, SeQuent Scientific announced the launch of veterinary medicine Halofusol (oral solution) in 19 European countries. Halofusol is 0.5 mg/ml oral anti-protozoal solution for the prevention and reduction of diarrhea in new-born calves. This in turn is expected to aid in the growth of the market.

Figure 1. Global Veterinary Healthcare Market Share (%), by Region, 2022

Veterinary Healthcare  | Coherent Market Insights

Global Veterinary Healthcare Market Drivers:

Increase in prevalence/incidence of zoonosis diseases across the globe is expected to boost growth of the global veterinary healthcare market over the forecast period. The World Health Organization (WHO) defines zoonosis as any infection that is naturally transmissible from vertebrate animals to humans. Many diseases related to zoonoses have led to a major outbreak in the world. For instance, the outbreak of COVID-19 (global pandemic) is an unrelenting demonstration of the devastating impact of zoonotic disease, whereby viruses jump from animals to infect humans. Thus, the focus on veterinary health care is increasing at a rapid pace.

Favorable initiatives by governments and animal welfare associations are expected to augment the growth of the global veterinary healthcare market during the forecast period. Many governments around the world are taking definite measures to enhance the management of animal healthcare in terms of diagnosis and treatment. For instance, the United States is among the major regions across the world which highly support the healthcare of veterinary animals, both companion animals and production animals. This in turn is expected to increase the focus on veterinary healthcare, driving the growth of the global veterinary healthcare market.

Global Veterinary Healthcare Market Opportunities:

Increase in focus on the veterinary healthcare is expected to offer significant growth opportunities for players in the global veterinary healthcare market. For instance, market players are focusing on developing and launching novel products in the market for effective veterinary healthcare. In July 2020, Antech Diagnostics announced that the novel blood test for canine inflammatory bowel disease (IBD), also called canine chronic enteropathy (CCE), is now available. It is a non-invasive test that incorporates data from biomarkers, which provide objective measurements of disease, to allow rapid, accurate diagnosis of consistent with CE/IBD or not consistent with CE/IBD.

Increase in adoption of pets during the pandemic (COVID-19) is expected to offer lucrative growth opportunities for players in the veterinary healthcare market. For instance, several animal shelters, pet stores, private breeders, and non-profit rescue organizations have seen an increase in consumer demand during the pandemic. Foster Inc., a non-profit organization, claimed to register more than 1,000% increase in foster applications during the pandemic in New York, the epicenter of COVID-19 cases in the United States. This in turn is expected to increase demand for veterinary healthcare in the U.S., driving the growth of the market.

CMI table icon

Veterinary Healthcare Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 30,368.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 9.0% 2028 Value Projection: US$ 55,657.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product: Therapeutics and Diagnostics
  • By Animal Type: Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals
Companies covered:

Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.

Growth Drivers:
  • Increase in prevalence/incidence of zoonosis diseases
  • Favorable initiatives by governments and animal welfare associations
Restraints & Challenges:
  • High cost of veterinary healthcare services/solutions
  • Availability of counterfeit products or drugs

Global Veterinary Healthcare Market Trends:

Advancements in the field of veterinary healthcare is expected to flourish the veterinary healthcare market during the forecast period owing to respective benefits. Artificial intelligence (AI), virtual reality (VR), 3D imaging, and wearable medical imaging devices are few of the technologies that are expected to pave the way for future advancements in the field of veterinary diagnostic imaging around the world. This trend is expected to continue over the forecast period.

Moreover, with the increase in demand for meat worldwide and increasing consumer awareness regarding the quality of meat as well as animal by-products, the demand for veterinary healthcare is also increasing with a rapid pace. This in turn has increased or increasing the demand for animal or veterinary healthcare across the globe. This trend is also expected to continue during the forecast period, driving the growth of the market.

Global Veterinary Healthcare Market Restraints:

High cost of veterinary healthcare services/solutions is expected to hamper the growth of the global veterinary healthcare market. For instance, veterinary care spending has been steadily rising, with U.S. consumers spent US$ 123.6 billion in 2021 on veterinarian care and product sales, according to the American Pet Products Association (APPA). Cost effectiveness is a major concern regarding veterinary healthcare, which in turn is restraining the market growth.

Availability of counterfeit products or drugs is expected to hinder growth of the global veterinary healthcare market. For instance, counterfeit pet medications are a growing problem, and they pose a real danger to the beloved animals. Counterfeit medications not only lack safety and efficacy for animals, but also pose a risk to human safety. The prevalence of illegal veterinary medicine is quite high in Japan, New Zealand, and Australia, as per the data provided by Health for Animals.

Figure 2. Global Veterinary Healthcare Market Share (%), by Product, 2022

Veterinary Healthcare  | Coherent Market Insights

Global Veterinary Healthcare Market Segmentation:

The global veterinary healthcare market report is segmented into Product, Animal Type, and Geography.

Based on Product, the global veterinary healthcare market is segmented into Therapeutics and Diagnostics. Out of which, Therapeutics Segment is expected to dominate the global veterinary healthcare market over the forecast period and this is attributed to the rise in prevalence/incidence of zoonosis diseases across the globe. This in turn has increased and/or increasing the demand for veterinary healthcare therapeutics.

Based on Animal Type, the market is segmented into Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals. Out of which, Dogs and Cats Segment is expected to dominate the market during the forecast period and this is attributed to the increase in adoption of companion animals, such as cats and dogs.

Horses Segment is also expected to witness significant growth in the near future and this is owing to the increase in cases of orthopedic problems in horses.

Global Veterinary Healthcare Market: Key Developments

In May 2020, Krka tovarna zdravil d Novo mesto, European pharmaceutical company, announced the launch of Prinocate (moxidectin and imidacloprid), prescription-only spot-on ectoparasiticide, for cats and dogs.

In January 2020, Whistle Labs launched Whistle Fit, which is specifically designed for pet health and fitness. It works as a preventative tool for the detection of itching and licking, and it has the capability of monitoring sleep in animals.

In August 2019, Boehringer Ingelheim launched a digital tool Dontstall.com, to help veterinarians diagnose equine protozoal myeloencephalitis (EPM), a protozoal disease that causes inflammation of the brain and/or spinal cord in horses.

Global Veterinary Healthcare Market: Key Companies Insights

The global veterinary healthcare market is highly competitive. This is attributed to the increase in awareness among people about veterinary healthcare, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global veterinary healthcare market are Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.

*Definition: Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of both domestic and wild animals.

Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of domestic and wild animals, as well as to prevent transmission of veterinary diseases (zoonotic and chronic) worldwide. Early detection is key when it comes to treating health problems in animals.

Market Dynamics:

Increase in incidence/prevalence of zoonosis diseases, increase in focus on veterinary healthcare, favorable initiatives by governments and animal welfare associations, increase in awareness about veterinary healthcare, rise in adoption of pets, and introduction of novel products are major factors expected to drive growth of the global veterinary healthcare market.

For instance, in September 2019, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) launched the 11th annual vaccination campaign for 2019-2020 against diseases affecting animals in the Emirate of Abu Dhabi. The campaign comes as part of ADAFSA's great support for livestock breeders in the emirate, to promote the best practices related to animal farming.

Moreover, in May 2020, Felix Pharmaceuticals Pvt. Ltd. announced that the U.S. Food and Drug Administration (FDA) approved its ‘Enrofloxacin Flavored Tablets’, for the treatment of diseases associated with bacteria.

Key features of the study:

  • This report provides in-depth analysis of the global veterinary healthcare market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global veterinary healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global veterinary healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary healthcare market.

Detailed Segmentation:

  • Global Veterinary Healthcare Market, By Product:
    • Therapeutics
    • Diagnostics
  • Global Veterinary Healthcare Market, By Animal Type:
    • Dogs and Cats
    • Horses
    • Ruminants
    • Swine
    • Poultry
    • Other Animals
  • Global Veterinary Healthcare Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Zoetis Inc.
    • Virbac SA
    • Vetoquinol SA
    • Phibro Animal Health
    • Merck & Co. Inc.
    • IDEXX Laboratories
    • Ceva SantE Animale
    • BioMérieux SA
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH

Frequently Asked Questions

The global veterinary healthcare market size is estimated to be valued at US$ 30,368.5 Million in 2021 and is expected to exhibit a CAGR of 9.0% between 2022 and 2028.
Increase in prevalence/incidence of zoonosis diseases and favorable initiatives by governments and animal welfare associations is fueling the market.
The Therapeutics segment is the leading product segment in the market.
High cost of veterinary healthcare services/solutions and the availability of counterfeit products or drugs are major factors restraining market.
Major players operating in the market are Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMérieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo